Folgen
Olga Guryanova
Titel
Zitiert von
Zitiert von
Jahr
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
S Turcan, D Rohle, A Goenka, LA Walsh, F Fang, E Yilmaz, C Campos, ...
Nature 483 (7390), 479-483, 2012
21112012
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
O Abdel-Wahab, J Gao, M Adli, A Dey, T Trimarchi, YR Chung, C Kuscu, ...
Journal of Experimental Medicine 210 (12), 2641-2659, 2013
3592013
Cancer stem cells in glioblastoma—molecular signaling and therapeutic targeting
Z Huang, L Cheng, OA Guryanova, Q Wu, S Bao
Protein & cell 1 (7), 638-655, 2010
3052010
Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3
OA Guryanova, Q Wu, L Cheng, JD Lathia, Z Huang, J Yang, ...
Cancer cell 19 (4), 498-511, 2011
2742011
Curaxins: anticancer compounds that simultaneously suppress NF-κB and activate p53 by targeting FACT
AV Gasparian, CA Burkhart, AA Purmal, L Brodsky, M Pal, M Saranadasa, ...
Science translational medicine 3 (95), 95ra74-95ra74, 2011
2552011
Elevated invasive potential of glioblastoma stem cells
L Cheng, Q Wu, OA Guryanova, Z Huang, Q Huang, JN Rich, S Bao
Biochemical and biophysical research communications 406 (4), 643-648, 2011
2442011
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling
OA Guryanova, K Shank, B Spitzer, L Luciani, RP Koche, ...
Nature medicine 22 (12), 1488-1495, 2016
2402016
L1CAM regulates DNA damage checkpoint response of glioblastoma stem cells through NBS1
L Cheng, Q Wu, Z Huang, OA Guryanova, Q Huang, W Shou, JN Rich, ...
The EMBO journal 30 (5), 800-813, 2011
2062011
Loss of Dnmt3a immortalizes hematopoietic stem cells in vivo
M Jeong, HJ Park, H Celik, EL Ostrander, JM Reyes, A Guzman, ...
Cell reports 23 (1), 1-10, 2018
1942018
Deubiquitylase HAUSP stabilizes REST and promotes maintenance of neural progenitor cells
Z Huang, Q Wu, OA Guryanova, L Cheng, W Shou, JN Rich, S Bao
Nature cell biology 13 (2), 142-152, 2011
1742011
CHZ868, a type II JAK2 inhibitor, reverses type I JAK inhibitor persistence and demonstrates efficacy in myeloproliferative neoplasms
SC Meyer, MD Keller, S Chiu, P Koppikar, OA Guryanova, F Rapaport, ...
Cancer cell 28 (1), 15-28, 2015
1502015
Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity
Y Kim, E Kim, Q Wu, O Guryanova, M Hitomi, JD Lathia, D Serwanski, ...
Genes & development 26 (11), 1247-1262, 2012
1422012
Facilitates chromatin transcription complex is an “accelerator” of tumor transformation and potential marker and target of aggressive cancers
H Garcia, JC Miecznikowski, A Safina, M Commane, A Ruusulehto, ...
Cell reports 4 (1), 159-173, 2013
1382013
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Y Shi, OA Guryanova, W Zhou, C Liu, Z Huang, X Fang, X Wang, C Chen, ...
Science translational medicine 10 (443), eaah6816, 2018
1242018
Epigenetic identity in AML depends on disruption of nonpromoter regulatory elements and is affected by antagonistic effects of mutations in epigenetic modifiers
JL Glass, D Hassane, BJ Wouters, H Kunimoto, R Avellino, ...
Cancer discovery 7 (8), 868-883, 2017
1122017
Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells
OA Guryanova, YK Lieu, FE Garrett-Bakelman, B Spitzer, JL Glass, ...
Leukemia 30 (5), 1133-1142, 2016
722016
Complex mutual regulation of facilitates chromatin transcription (FACT) subunits on both mRNA and protein levels in human cells
A Safina, H Garcia, M Commane, O Guryanova, S Degan, K Kolesnikova, ...
Cell cycle 12 (15), 2423-2434, 2013
602013
Targeting transcription factor NFκB: comparative analysis of proteasome and IKK inhibitors
AV Gasparian, OA Guryanova, DV Chebotaev, AA Shishkin, ...
Cell Cycle 8 (10), 1559-1566, 2009
582009
The impact of inflammation-induced tumor plasticity during myeloid transformation
A Yeaton, G Cayanan, S Loghavi, I Dolgalev, EM Leddin, CE Loo, ...
Cancer discovery 12 (10), 2392-2413, 2022
352022
Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions
P Nowialis, K Lopusna, J Opavska, SL Haney, A Abraham, P Sheng, ...
Nature communications 10 (1), 4374, 2019
332019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20